Literature DB >> 21798787

Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian university hospital.

Irena Franolić-Kukina1, Branka Bedenić, Ana Budimir, Zoran Herljević, Jasmina Vraneš, Paul G Higgins.   

Abstract

BACKGROUND: From July to October 2008, 34 Acinetobacter baumannii isolates were involved in an outbreak at the Clinical Hospital Center, Zagreb. The aim of this study was to characterize the mechanisms of carbapenem resistance in our A. baumannii isolates and determine their epidemiology.
METHODS: Antibiotic susceptibilities were determined by broth microdilution. PCR was used to detect the presence of carbapenemases. Genotyping of the isolates was performed by random amplification of polymorphic DNA (RAPD), pulsed-field gel electrophoresis (PFGE), and repetitive sequence-based PCR (rep-PCR).
RESULTS: Thirty-three carbapenem-resistant isolates were positive for the acquired bla(OXA-72) and one unrelated isolate was positive for bla(OXA-58). The bla(OXA-72)-positive isolates were shown to be clonally related by RAPD, rep-PCR, and PFGE.
CONCLUSIONS: On the basis of susceptibility testing, β-lactamase characterization, and genotyping of the isolates we can conclude that clonal spread of endemic isolates was responsible for the high frequency of OXA-72-positive multidrug-resistant A. baumannii in this setting. Most of the isolates originated from the intensive care unit indicating local dissemination within the hospital and pointing to the potential source of isolates.
Copyright © 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798787     DOI: 10.1016/j.ijid.2011.05.016

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia.

Authors:  Laurent Dortet; Rémy A Bonnin; Sandrine Bernabeu; Lélia Escaut; Daniel Vittecoq; Delphine Girlich; Dilek Imanci; Nicolas Fortineau; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in the United States, 2013-2017.

Authors:  Susannah L McKay; Nicholas Vlachos; Jonathan B Daniels; Valerie S Albrecht; Valerie A Stevens; J Kamile Rasheed; J Kristie Johnson; Joseph D Lutgring; Maria Sjölund-Karlsson; Alison Laufer Halpin
Journal:  Microb Drug Resist       Date:  2022-05-27       Impact factor: 2.706

3.  Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009-2010.

Authors:  M Vranić-Ladavac; B Bedenić; F Minandri; M Ištok; Z Bošnjak; S Frančula-Zaninović; R Ladavac; P Visca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-06       Impact factor: 3.267

Review 4.  Mechanisms of Resistance in Gram-Negative Urinary Pathogens: From Country-Specific Molecular Insights to Global Clinical Relevance.

Authors:  Branka Bedenić; Tomislav Meštrović
Journal:  Diagnostics (Basel)       Date:  2021-04-28

5.  The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates.

Authors:  Bojana Lukovic; Ina Gajic; Ivica Dimkic; Dusan Kekic; Sanja Zornic; Tatjana Pozder; Svetlana Radisavljevic; Nataša Opavski; Milan Kojic; Lazar Ranin
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-06       Impact factor: 4.887

6.  The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement.

Authors:  Bence Balázs; Zoltán Tóth; Fruzsina Nagy; Renátó Kovács; Hajnalka Tóth; József Bálint Nagy; Ákos Tóth; Krisztina Szarka; László Majoros; Gábor Kardos
Journal:  Antibiotics (Basel)       Date:  2021-01-29

7.  Diversity of Oxacillinases and Sequence Types in Carbapenem-Resistant Acinetobacter baumannii from Austria.

Authors:  Andrea J Grisold; Josefa Luxner; Branka Bedenić; Magda Diab-Elschahawi; Michael Berktold; Agnes Wechsler-Fördös; Gernot E Zarfel
Journal:  Int J Environ Res Public Health       Date:  2021-02-23       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.